Firmusan
FDA Label NDC 73479-015

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sanpharmacy Inc. for the product Firmusan (NDC 73479-015). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding indications, purpose, dosage, active ingredients, inactive ingeredients, warnings, otc - keep out of reach of children, other, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Indications

→ Purpose

→ Dosage

→ Active Ingredients

→ Inactive Ingeredients

→ Warnings

→ Otc - Keep Out Of Reach Of Children

→ Other

→ Liability Statement

→ Storage And Handling

→ Package Label.principal Display Panel

Indications

For joint and serous membrane inflammation

Purpose

Relieves symptoms of joint and serous membrane inflammation

Dosage

1-2 capsules per week, taken at least 1 hour before eating

Active Ingredients

Bacillus firmus 6X

Inactive Ingeredients

mannitol

Warnings

If pregnant or breast-feeding, ask a health professional before use.
______________________________
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.
______________________________
When using this product
▪ do not use more than directed
______________________________
If symptoms persist more than 5 days, contact a licensed practitioner.
______________________________
Tamper Evident: Do not use product if tamper evident strip is broken. To report adverse events, contact MEDsan Inc. at 1-855-462-6334.